A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.
暂无分享，去创建一个
J. Mellors | J. Currier | A. Landay | T. Wilkin | R. Gandhi | R. Gulick | N. Lin | Christina M Lalama | L. Fox | A. Tenorio | H. Ribaudo | J. McKinnon | C. Lalama